These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3826096)

  • 21. Medical treatment of hypercalcemia.
    Schaiff RA; Hall TG; Bar RS
    Clin Pharm; 1989 Feb; 8(2):108-21. PubMed ID: 2521820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
    Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
    Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumoral hypercalcemia: physiopathology and treatment].
    Rizzoli R; Jung A; Bonjour JP
    Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein.
    Hoekman K; Tjandra YI; Papapoulos SE
    Cancer; 1991 Aug; 68(3):642-7. PubMed ID: 2065286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clodronate in hypercalcemia of malignancy.
    Bonjour JP; Rizzoli R
    Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia.
    Singer FR
    Semin Oncol; 1990 Apr; 17(2 Suppl 5):34-9. PubMed ID: 2110387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled study.
    Hasling C; Charles P; Mosekilde L
    Eur J Clin Invest; 1986 Oct; 16(5):433-7. PubMed ID: 3100312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy.
    Fatemi S; Singer FR; Rude RK
    Calcif Tissue Int; 1992 Feb; 50(2):107-9. PubMed ID: 1571826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical management of hypercalcaemia.
    Ralston SH
    Br J Clin Pharmacol; 1992 Jul; 34(1):11-20. PubMed ID: 1633063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.
    Harinck HI; Bijvoet OL; Plantingh AS; Body JJ; Elte JW; Sleeboom HP; Wildiers J; Neijt JP
    Am J Med; 1987 Jun; 82(6):1133-42. PubMed ID: 3300303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
    Leyland-Jones B
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hypercalcemia in relation to pathophysiology.
    Bonjour JP; Rizzoli R; Hirschel-Scholz S; Caverzasio J
    Bone; 1987; 8 Suppl 1():S29-33. PubMed ID: 2825740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study.
    Flores JF; Singer FR; Rude RK
    Miner Electrolyte Metab; 1991; 17(6):390-5. PubMed ID: 1823390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
    Bonjour JP; Philippe J; Guelpa G; Bisetti A; Rizzoli R; Jung A; Rosini S; Kanis JA
    Bone; 1988; 9(3):123-30. PubMed ID: 2971382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR
    Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.